|
TEX2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.030300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.585800E-04 |
| Normal-vs-Stage2 |
1.380010E-01 |
| Normal-vs-Stage3 |
8.439200E-01 |
| Normal-vs-Stage4 |
9.054400E-01 |
| Stage1-vs-Stage2 |
6.719000E-01 |
| Stage1-vs-Stage3 |
3.501200E-01 |
| Stage1-vs-Stage4 |
4.292000E-01 |
| Stage2-vs-Stage3 |
4.732400E-01 |
| Stage2-vs-Stage4 |
5.468400E-01 |
| Stage3-vs-Stage4 |
9.690200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.511860E-02 |
| Normal-vs-AfricanAmerican |
1.056960E-01 |
| Normal-vs-Asian |
6.110400E-01 |
| Caucasian-vs-AfricanAmerican |
8.210600E-01 |
| Caucasian-vs-Asian |
3.115400E-01 |
| AfricanAmerican-vs-Asian |
2.471600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.20529999501218E-08 |
| Normal-vs-Female |
1.617990E-01 |
| Male-vs-Female |
1.140410E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.605370E-01 |
| Normal-vs-Extreme_Weight |
5.66319999784071E-08 |
| Normal-vs-Obese |
7.358200E-01 |
| Normal-vs-Extreme_Obese |
4.298000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.565350E-01 |
| Normal_Weight-vs-Obese |
5.522800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.033800E-01 |
| Extreme_Weight-vs-Obese |
8.154000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.315960E-01 |
| Obese-vs-Extreme_Obese |
7.115200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.599950E-01 |
| Normal-vs-Age(41-60Yrs) |
1.815990E-01 |
| Normal-vs-Age(61-80Yrs) |
6.634200000466E-07 |
| Normal-vs-Age(81-100Yrs) |
6.6070000004359E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.159030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.833900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.732300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.455710E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.680870E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.271800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.22510000000187E-06 |
| Normal-VS-Type2 PRCC |
1.976300E-02 |
| Normal-VS-KIRP CIMP |
1.185840E-01 |
| Normal-VS-Unclassified PRCC |
8.894600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.873000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.820400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.820820E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.168100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.963800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.202030E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.323400E-01 |
| Normal-vs-N1 |
6.321800E-01 |
| Normal-vs-N2 |
6.710200E-01 |
| N0-vs-N1 |
4.019200E-01 |
| N0-vs-N2 |
5.665600E-01 |
| N1-vs-N2 |
8.274600E-01 |
|
|
